4//SEC Filing
Bonello Michael J. 4
Accession 0001104659-21-083610
CIK 0001613859other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 5:27 PM ET
Size
21.8 KB
Accession
0001104659-21-083610
Insider Transaction Report
Form 4
Bonello Michael J.
Exec VP & CFO
Transactions
- Exercise/Conversion
Common Stock
2021-06-17$103.30/sh+8,556$883,835→ 64,415 total - Sale
Common Stock
2021-06-17$168.17/sh−24,389$4,101,498→ 39,826 total - Exercise/Conversion
Stock Options (Right to Buy)
2021-06-17−35,661→ 20,000 totalExercise: $81.61Exp: 2028-04-26→ Common Stock (35,661 underlying) - Exercise/Conversion
Stock Options (Right to Buy)
2021-06-17−8,334→ 16,666 totalExercise: $95.94Exp: 2029-08-13→ Common Stock (8,334 underlying) - Exercise/Conversion
Stock Options (Right to Buy)
2021-06-17−8,556→ 17,114 totalExercise: $103.30Exp: 2030-06-01→ Common Stock (8,556 underlying) - Exercise/Conversion
Common Stock
2021-06-17$81.61/sh+35,661$2,910,294→ 47,525 total - Sale
Common Stock
2021-06-17$166.70/sh−200$33,340→ 64,215 total - Sale
Common Stock
2021-06-17$169.05/sh−22,587$3,818,332→ 17,239 total - Sale
Common Stock
2021-06-17$169.67/sh−5,375$911,976→ 11,864 total - Exercise/Conversion
Common Stock
2021-06-17$95.94/sh+8,334$799,564→ 55,859 total
Footnotes (8)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $166.55 to $166.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2), (3), (4) and (5) of this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $167.57 to $168.56, inclusive.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $168.57 to $169.55, inclusive.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $169.57 to $169.83, inclusive.
- [F6]12,877 options vested on April 26, 2019 and 4,339 options vested on April 26, 2020 upon satisfaction of certain performance criteria.
- [F7]The option vests in three equal annual installments of 8,334 beginning on August 13, 2020.
- [F8]The option vests in three equal annual installments of 8,556 beginning on June 1, 2021.
Documents
Issuer
PRA Health Sciences, Inc.
CIK 0001613859
Entity typeother
Related Parties
1- filerCIK 0001738327
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 5:27 PM ET
- Size
- 21.8 KB